Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism

HCC has remained one of the challenging cancers to treat, owing to the paucity of drugs targeting the critical survival pathways. Considering the cancer cells are deficient in DNase activity, the increase of an autonomous apoptisis endonuclease should be a reasonable choice for cancer treatment. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yusha, Yang, Kang, Liu, Pengpeng, Ma, Dong, Lei, Ping, Liu, Quanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692146/
https://www.ncbi.nlm.nih.gov/pubmed/34975319
http://dx.doi.org/10.7150/ijbs.57919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692146/
https://www.ncbi.nlm.nih.gov/pubmed/34975319
http://dx.doi.org/10.7150/ijbs.57919

Ejemplares similares